Skip to main content

Table 4 SIV-specific CD8+ T cell responses before and after SIVmac055 challenge

From: Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques

Macaque Daya SIVenvb SIVgagb SIVpolb SIVnefb Tenofovirc
1494 (-35) 60 240 155 95 No
  (-15) 160 520 220 205  
  9 45 255 115 120  
  265 35 180 40 90  
1512 (-35) 30 290 190 50 No
  (-15) 25 105 115 35  
  9 40 95 60 15  
  265 475 545 440 349  
1488 (-35) 620 170 10 50 Yes
  (-15) 2365 510 70 80  
  9 1533 458 83 168  
  265 3305 1335 205 160  
1514 (-35) 85 190 15 15 Yes
  (-15) 245 380 60 30  
  9 65 85 25 0  
  265 265 535 55 70  
  1. aDays before and after SIVmac055 challenge
  2. bData is expressed as the number of spot-forming cells (SFC) per 106 PBMC
  3. cTenofovir treatment for a total of 6 weeks at a dose of 30 mg/kg of body weight